| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |